LSE:BVXP (Bioventix PLC)

About BVXP

Bioventix develops high-affinity sheep monoclonal antibodies for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.
  • Bioventix PLC (LSE: BVXP) Latest News

    Syringe and vial on blue background
    Investing Articles

    Looking for shares to buy now? 1 biotech stock I’d buy today

    Looking for shares to buy now? Zaven Boyrazian analyses a biotech firm that is vital to the development of new…

    Read more »

    Investing Articles

    Look to the future! I’d buy these AIM stocks today

    AIM stocks are often risky investments, but they can also see tremendous gains. One Fool looks at his top picks…

    Read more »

    Investing Articles

    What market crash? These 3 growth stocks have bounced back hard

    Paul Summers highlights three growth stocks that have rebounded strongly from March's market turmoil.

    Read more »

    Investing Articles

    Can you afford to overlook this solid-looking growth and dividend stock?

    This share is on my radar, and I’m poised to pounce!

    Read more »

    Investing Articles

    2 secret growth stocks I think are worth adding to your watchlist

    Paul Summers highlights two under-the-radar stocks he thinks warrant more attention from growth investors.

    Read more »

    Investing Articles

    2 secret small-cap growth stocks I think you need to know about

    These market minnows have been quietly making their owners a lot of money. Paul Summers take a closer look.

    Read more »

    Investing Articles

    Why I think this top small-cap stock could make you a fortune

    If you’re looking for a company that could produce triple-digit returns then I’d check out this little known small-cap.

    Read more »

    Investing Articles

    A FTSE 100 dividend growth stock I’d buy today and one top performer I’d consider selling

    Why I’d recycle my profits from this small-cap into this evergreen FTSE 100 (INDEXFTSE: UKX) big-cap.

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca plc over this soaring growth stock

    Harvey Jones says AstraZeneca plc (LON: AZN) could hit new peaks and put this biotechnology upstart in its place.

    Read more »

    Investing Articles

    Should you buy this growth company after profits soar 40%?

    The market reacted negatively to this company's explosive profit growth today. One Fool takes a closer look.

    Read more »

    Investing Articles

    Why this small-cap stock could be the UK’s most exciting investment opportunity right now

    Edward Sheldon identifies a fast-growing small-cap biotech stock that he believes has considerable potential.

    Read more »

    Investing Articles

    These small-cap growth stocks could be millionaire-makers

    I think these two growers look set to advance further.

    Read more »